Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (215) 215
Newspaper Article (162) 162
Patent (7) 7
Book / eBook (5) 5
Book Review (2) 2
Web Resource (2) 2
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (132) 132
science & technology (124) 124
life sciences & biomedicine (119) 119
male (99) 99
female (89) 89
middle aged (69) 69
biological and medical sciences (66) 66
medical sciences (63) 63
aged (53) 53
adult (46) 46
abridged index medicus (44) 44
psychiatry (36) 36
general & internal medicine (33) 33
double-blind method (29) 29
treatment outcome (26) 26
adolescent (25) 25
animals (25) 25
neurosciences & neurology (23) 23
grief (22) 22
child (21) 21
cardiology. vascular system (20) 20
clinical neurology (20) 20
dermatology (20) 20
neurosciences (20) 20
psychology (20) 20
research (20) 20
social sciences (20) 20
psychology. psychoanalysis. psychiatry (19) 19
rats (19) 19
medicine, general & internal (18) 18
pharmacology. drug treatments (18) 18
care and treatment (17) 17
comorbidity (17) 17
bereavement (16) 16
child, preschool (15) 15
cholesterol, ldl - blood (15) 15
critical care medicine (15) 15
drug therapy (15) 15
rats, sprague-dawley (15) 15
cholesterol (14) 14
cholesterol, hdl - blood (14) 14
depressive disorder - diagnosis (14) 14
anxiety disorders - psychology (13) 13
brain (13) 13
cardiovascular system & cardiology (13) 13
depressive disorder - psychology (13) 13
hypercholesterolemia - drug therapy (13) 13
obama, barack (13) 13
original articles (13) 13
psychopathology. psychiatry (13) 13
risk factors (13) 13
traumatic brain injury (13) 13
aged, 80 and over (12) 12
anticholesteremic agents - therapeutic use (12) 12
anxiety disorders - diagnosis (12) 12
blood pressure (12) 12
heart (12) 12
injuries (12) 12
age factors (11) 11
analysis (11) 11
atherosclerosis (11) 11
cardiovascular disease (11) 11
disease models, animal (11) 11
heptanoic acids - therapeutic use (11) 11
psychology, clinical (11) 11
pyrroles - therapeutic use (11) 11
quinolines - therapeutic use (11) 11
severity of illness index (11) 11
survivors (11) 11
atorvastatin calcium (10) 10
combined modality therapy (10) 10
depression (10) 10
diagnosis (10) 10
dose-response relationship, drug (10) 10
follow-up studies (10) 10
general aspects (10) 10
lipids (10) 10
lipoproteins (10) 10
louisiana (10) 10
lovastatin - therapeutic use (10) 10
adult and adolescent clinical studies (9) 9
anxiety (9) 9
blood and lymphatic vessels (9) 9
budgeting -- virginia (9) 9
complicated grief (9) 9
hypercholesterolemia (9) 9
risk (9) 9
sex factors (9) 9
traumatic grief (9) 9
anticholesteremic agents - adverse effects (8) 8
brain damage (8) 8
cardiac & cardiovascular systems (8) 8
cholesterol - blood (8) 8
clinical trials (8) 8
depression, mental (8) 8
drug therapy, combination (8) 8
evaluation (8) 8
incidence (8) 8
lovastatin (8) 8
lovastatin - adverse effects (8) 8
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Torcetrapib and carotid intima-media thickness in mixed dyslipidaemia (RADIANCE 2 study): a randomised, double-blind trial
by Bots, Michiel L, Dr and Visseren, Frank L, MD and Evans, Gregory W, MA and Riley, Ward A, Prof and Revkin, James H, MD and Tegeler, Charles H, Prof and Shear, Charles L, DrPH and Duggan, William T, PhD and Vicari, Ralph M, MD and Grobbee, Diederick E, Prof and Kastelein, John J, Prof and for the RADIANCE 2 Investigators and RADIANCE 2 Investigators
The Lancet (British edition), ISSN 0140-6736, 2007, Volume 370, Issue 9582, pp. 153 - 160
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Carotid Arteries - drug effects | Dyslipidemias - drug therapy | Double-Blind Method | Cholesterol - blood | Heptanoic Acids - therapeutic use | Humans | Middle Aged | Male | Heptanoic Acids - adverse effects | Anticholesteremic Agents - adverse effects | Tunica Intima - drug effects | Atorvastatin Calcium | Dyslipidemias - blood | Anticholesteremic Agents - therapeutic use | Tunica Intima - pathology | Pyrroles - adverse effects | Female | Blood Pressure - drug effects | Quinolines - therapeutic use | Pyrroles - therapeutic use | Quinolines - adverse effects | Studies | Medical research | Digital imaging | Diet | Mortality | Cardiovascular disease | Metabolic syndrome | Protocol | Low density lipoprotein | Patients | Cholesterol | Veins & arteries | Lipoproteins (low density) | Laboratories | Clinical trials | Segments | Density | Evidence-based medicine | Carotid arteries | Blood | Proteins | Randomization | Ultrasonic imaging | Radiance | Atherosclerosis | Blood pressure | Lipoproteins (high density) | Ultrasound | Media | Triglycerides | Cholesteryl ester transfer protein | Arteriosclerosis | Atorvastatin | Titration | Diabetes | Health risk assessment | Mercury | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Escitalopram for Older Adults With Generalized Anxiety Disorder: A Randomized Controlled Trial
by Lenze, Eric J and Rollman, Bruce L and Shear, M. Katherine and Dew, Mary Amanda and Pollock, Bruce G and Ciliberti, Caroline and Costantino, Michelle and Snyder, Sara and Shi, Peichang and Spitznagel, Edward and Andreescu, Carmen and Butters, Meryl A and Reynolds, Charles F
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 01/2009, Volume 301, Issue 3, pp. 295 - 303
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | General aspects | Anxiety disorders. Neuroses | Miscellaneous | Psychology. Psychoanalysis. Psychiatry | Adult and adolescent clinical studies | Biological and medical sciences | Medical sciences | Neuropharmacology | Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) | Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer | Psychopharmacology | Pharmacology. Drug treatments | Psychopathology. Psychiatry | Psychiatric Status Rating Scales | Humans | Middle Aged | Serotonin Uptake Inhibitors - therapeutic use | Aged, 80 and over | Citalopram - therapeutic use | Female | Male | Aged | Anxiety Disorders - drug therapy | Psychological aspects | Usage | Care and treatment | Generalized anxiety disorder | Memory in old age | Placebos | Serotonin uptake inhibitors | Comparative analysis | Inhibitor drugs | Product safety | Anxieties | Older people | Medical treatment | Placebo effect | Index Medicus | Abridged Index Medicus | Preliminary Communication
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary Disease
by LaRosa, John C and Grundy, Scott M and Waters, David D and Shear, Charles and Barter, Philip and Fruchart, Jean-Charles and Gotto, Antonio M and Greten, Heiner and Kastelein, John J.P and Shepherd, James and Wenger, Nanette K and TNT Investigators and Treating to New Targets (TNT) Investigators
The New England journal of medicine, ISSN 0028-4793, 04/2005, Volume 352, Issue 14, pp. 1425 - 1435
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Cardiology. Vascular system | Heart | Biological and medical sciences | General aspects | Medical sciences | Coronary heart disease | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Prospective Studies | Cardiovascular Diseases - prevention & control | Cholesterol - blood | Heptanoic Acids - therapeutic use | Humans | Middle Aged | Male | Risk | Alanine Transaminase - blood | Heptanoic Acids - adverse effects | Incidence | Dose-Response Relationship, Drug | Pyrroles - administration & dosage | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Heptanoic Acids - administration & dosage | Pyrroles - adverse effects | Adult | Cholesterol, LDL - blood | Female | Pyrroles - therapeutic use | Coronary Disease - blood | Anticholesteremic Agents - adverse effects | Atorvastatin Calcium | Anticholesteremic Agents - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Anticholesteremic Agents - administration & dosage | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Triglycerides - blood | Coronary Disease - drug therapy | Aged | Measurement | Cholesterol, LDL | Care and treatment | Lipids | Cardiovascular disease | Drug therapy | Patients | Low density lipoprotein | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Lipid-Reduction Variability and Antidrug-Antibody Formation with Bococizumab
by Ridker, Paul M and Tardif, Jean-Claude and Amarenco, Pierre and Duggan, William and Glynn, Robert J and Jukema, J. Wouter and Kastelein, John J.P and Kim, Albert M and Koenig, Wolfgang and Nissen, Steven and Revkin, James and Rose, Lynda M and Santos, Raul D and Schwartz, Pamela F and Shear, Charles L and Yunis, Carla and SPIRE Investigators
The New England journal of medicine, ISSN 0028-4793, 04/2017, Volume 376, Issue 16, pp. 1517 - 1526
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Hypercholesterolemia - immunology | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Follow-Up Studies | Humans | Middle Aged | Male | Treatment Outcome | Injections, Subcutaneous - adverse effects | Proprotein Convertase 9 - immunology | Hypercholesterolemia - drug therapy | Anticholesteremic Agents - adverse effects | Anticholesteremic Agents - immunology | Anticholesteremic Agents - therapeutic use | Proprotein Convertase 9 - antagonists & inhibitors | Lipids - blood | Proprotein Convertase 9 - blood | Antibodies - blood | Cholesterol, LDL - blood | Female | Antibodies, Monoclonal, Humanized - immunology | Complications and side effects | Treatment outcome | Immune response | Patient outcomes | Analysis | Dosage and administration | Antilipemic agents | Lipoproteins (low density) | Hyperlipidemia | Clinical trials | Lipids | Subtilisin | Patients | Low density lipoprotein | Cholesterol | Studies | Apolipoprotein B | Kexin | Monoclonal antibodies | Statins | Index Medicus | Abridged Index Medicus | Medicin och hälsovetenskap
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Optimizing Treatment of Complicated Grief: A Randomized Clinical Trial
by Shear, M. Katherine and Reynolds, Charles F and Simon, Naomi M and Zisook, Sidney and Wang, Yuanjia and Mauro, Christine and Duan, Naihua and Lebowitz, Barry and Skritskaya, Natalia
JAMA psychiatry (Chicago, Ill.), ISSN 2168-622X, 07/2016, Volume 73, Issue 7, pp. 685 - 694
Life Sciences & Biomedicine | Psychiatry | Science & Technology | Grief | Double-Blind Method | Comorbidity | Humans | Middle Aged | Depressive Disorder - diagnosis | Psychotherapy | Depressive Disorder - drug therapy | Male | Treatment Outcome | Combined Modality Therapy | Adjustment Disorders - diagnosis | Adjustment Disorders - drug therapy | Adjustment Disorders - psychology | Adult | Citalopram - therapeutic use | Female | Aged | Depressive Disorder - psychology | Usage | Care and treatment | Antidepressants | Health aspects | Citalopram | Index Medicus | Abridged Index Medicus | Depressive Disorders | Bereavement | SSRIs | Americans | Survivors | Traumatic Grief | Treatment Compliance | Randomized Clinical Trial | Treatment Effectiveness | Suicidality | Quality of Life | Adults | Psychotherapeutic Processes | Manual-Based Treatments | Avoidance
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Effect of Torcetrapib on the Progression of Coronary Atherosclerosis
by Nissen, Steven E and Tardif, Jean-Claude and Nicholls, Stephen J and Revkin, James H and Shear, Charles L and Duggan, William T and Ruzyllo, Witold and Bachinsky, William B and Lasala, Gabriel P and Tuzcu, E. Murat and ILLUSTRATE Investigators
The New England journal of medicine, ISSN 0028-4793, 03/2007, Volume 356, Issue 13, pp. 1304 - 1316
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Cardiology. Vascular system | Biological and medical sciences | General aspects | Medical sciences | Atherosclerosis (general aspects, experimental research) | Blood and lymphatic vessels | Cholesterol Ester Transfer Proteins - antagonists & inhibitors | Prospective Studies | Heptanoic Acids - therapeutic use | Humans | Middle Aged | Ultrasonography, Interventional | Male | Cholesterol Ester Transfer Proteins - adverse effects | Coronary Artery Disease - pathology | Adult | Cholesterol, LDL - blood | Female | Blood Pressure - drug effects | Drug Therapy, Combination | Pyrroles - therapeutic use | Double-Blind Method | Cholesterol, HDL - metabolism | Coronary Artery Disease - drug therapy | Anticholesteremic Agents - adverse effects | Disease Progression | Atorvastatin Calcium | Coronary Artery Disease - diagnostic imaging | Anticholesteremic Agents - therapeutic use | Cholesterol, HDL - blood | Aged | Cardiovascular Diseases - chemically induced | Quinolines - therapeutic use | Quinolines - adverse effects | Prevention | Causes of | Risk factors | Atherosclerosis | Lipoproteins | Ultrasonic imaging | Medical imaging | Clinical trials | Cardiovascular disease | Blood pressure | Cholesterol | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Effects of Torcetrapib in Patients at High Risk for Coronary Events
by Barter, Philip J and Caulfield, Mark and Eriksson, Mats and Grundy, Scott M and Kastelein, John J.P and Komajda, Michel and Lopez-Sendon, Jose and Mosca, Lori and Tardif, Jean-Claude and Waters, David D and Shear, Charles L and Revkin, James H and Buhr, Kevin A and Fisher, Marian R and Tall, Alan R and Brewer, Bryan and ILLUMINATE Investigators
The New England journal of medicine, ISSN 0028-4793, 11/2007, Volume 357, Issue 21, pp. 2109 - 2122
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Cardiology. Vascular system | Heart | Biological and medical sciences | General aspects | Medical sciences | Coronary heart disease | Cholesterol Ester Transfer Proteins - antagonists & inhibitors | Cardiovascular Diseases - drug therapy | Heptanoic Acids - therapeutic use | Humans | Middle Aged | Male | Heptanoic Acids - adverse effects | Coronary Disease - mortality | Cardiovascular Diseases - mortality | Pyrroles - adverse effects | Cholesterol, LDL - blood | Female | Drug Therapy, Combination | Pyrroles - therapeutic use | Double-Blind Method | Mortality | Anticholesteremic Agents - adverse effects | Atorvastatin Calcium | Coronary Disease - prevention & control | Anticholesteremic Agents - therapeutic use | Cholesterol, HDL - blood | Aged | Cardiovascular Diseases - chemically induced | Quinolines - therapeutic use | Quinolines - adverse effects | Clinical trials | Cardiovascular disease | Side effects | Pharmacology | Inhibitor drugs | Cholesterol | Index Medicus | Abridged Index Medicus | Medicin och hälsovetenskap
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Effect of Torcetrapib on Carotid Atherosclerosis in Familial Hypercholesterolemia
by Kastelein, John J.P and van Leuven, Sander I and Burgess, Leslie and Evans, Greg W and Kuivenhoven, Jan A and Barter, Philip J and Revkin, James H and Grobbee, Diederick E and Riley, Ward A and Shear, Charles L and Duggan, William T and Bots, Michiel L and RADIANCE 1 Investigators
The New England journal of medicine, ISSN 0028-4793, 04/2007, Volume 356, Issue 16, pp. 1620 - 1630
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Cardiology. Vascular system | Biological and medical sciences | General aspects | Medical sciences | Atherosclerosis (general aspects, experimental research) | Blood and lymphatic vessels | Carotid Arteries - drug effects | Cholesterol Ester Transfer Proteins - antagonists & inhibitors | Prospective Studies | Heptanoic Acids - therapeutic use | Humans | Middle Aged | Male | Quinolines - pharmacology | Atherosclerosis - etiology | Carotid Artery Diseases - pathology | Adult | Cholesterol, LDL - blood | Female | Hyperlipoproteinemia Type II - drug therapy | Drug Therapy, Combination | Pyrroles - therapeutic use | Carotid Artery Diseases - drug therapy | Hyperlipoproteinemia Type II - complications | Atherosclerosis - pathology | Atherosclerosis - drug therapy | Carotid Artery Diseases - etiology | Double-Blind Method | Hyperlipoproteinemia Type II - blood | Disease Progression | Atorvastatin Calcium | Anticholesteremic Agents - therapeutic use | Cholesterol, HDL - blood | Heterozygote | Carotid Arteries - pathology | Quinolines - therapeutic use | Anticholesteremic Agents - pharmacology | Hypercholesterolemia | High density lipoproteins | Atherosclerosis | Anticholesteremic agents | Dosage and administration | Research | Drug therapy | Cardiovascular disease | Diet | Apolipoproteins | Cholesterol | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Characteristics of depression in hemodialysis patients: symptoms, quality of life and mortality risk
by Drayer, Rebecca A and Piraino, Beth and Reynolds, Charles F and Houck, Patricia R and Mazumdar, Sati and Bernardini, Judith and Shear, M. Katherine and Rollman, Bruce L
General hospital psychiatry, ISSN 0163-8343, 2006, Volume 28, Issue 4, pp. 306 - 312
Depression | Hemodialysis | Mortality | Symptoms | Quality of life | Life Sciences & Biomedicine | Psychiatry | Science & Technology | Emergency and intensive care: renal failure. Dialysis management | Psychology. Psychoanalysis. Psychiatry | Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy | Adult and adolescent clinical studies | Psychopathology. Psychiatry | Mood disorders | Biological and medical sciences | Intensive care medicine | Medical sciences | Depressive Disorder, Major - etiology | Demography | Renal Dialysis - psychology | Risk Assessment | Humans | Middle Aged | Male | Depressive Disorder, Major - psychology | Renal Dialysis - mortality | Adolescent | Kidney Failure, Chronic - rehabilitation | Aged, 80 and over | Female | Surveys and Questionnaires | Aged | Quality of Life - psychology | Depressive Disorder, Major - diagnosis | Medical colleges | Kidney diseases | Patient outcomes | Depression, Mental | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights